CN Stock MarketDetailed Quotes

Zhejiang Shapuaisi Pharmaceutical (603168)

Watchlist
  • 6.51
  • -0.24-3.56%
Market Closed Apr 17 15:00 CST
2.44BMarket Cap-10.20P/E (TTM)

Zhejiang Shapuaisi Pharmaceutical (603168) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Eye drops186.92M40.39%
Diagnosis and treatment service126.6M27.36%
Cefixime79.71M17.22%
Other36.67M7.92%
Other business23.41M5.06%
Large infusion9.47M2.05%
View all

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical industry312.77M67.59%
Diagnosis and treatment service126.6M27.36%
Other business23.41M5.06%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
East China226.03M48.84%
Northeast China69.23M14.96%
Central China36.46M7.88%
South China31.95M6.90%
Southwest28.62M6.18%
North China28.43M6.14%
Other business23.41M5.06%
Northwest18.65M4.03%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More